Type 2 Diabetes and Gastrointestinal Cancers: Risk Associations and Awareness of Screening Challenges

Area of Science:

• Endocrinology
• Oncology
• Gastroenterology

Background:

• Type 2 diabetes (T2D) is increasingly linked to a higher risk of gastrointestinal (GI) cancers.
• Shared risk factors and biological mechanisms may underlie this association.

Purpose of the Study:

• To review evidence linking T2D and GI malignancies.
• To propose a clinical framework for risk-adapted cancer vigilance in T2D patients.

Main Methods:

• Narrative literature review.
• Focus on colorectal, pancreatic, liver, gastric, and biliary cancers in T2D.
• Examination of shared risk factors, biological mechanisms, and pathophysiology.

Main Results:

• Chronic hyperglycemia, hyperinsulinemia, insulin resistance, inflammation, and gut microbiota changes are implicated in T2D-associated cancer development.
• Current GI cancer screening guidelines lack T2D-specific recommendations.

Conclusions:

• T2D is an emerging risk factor for several GI malignancies.
• Clinicians should consider individualized GI cancer risk assessment for newly diagnosed T2D patients.
• Further research and prospective studies are needed to evaluate targeted screening strategies.